Shalom Lerrer

695 citations
17 papers · 507 indexed · h-index 9
Topics
Cancer Immunotherapy and Biomarkers (10 papers)Immune Cell Function and Interaction (7 papers)CAR-T cell therapy research (6 papers)
Journals
Journal of Biological ChemistrySHILAP Revista de lepidopterologíaFrontiers in Immunology

In The Last Decade

Shalom Lerrer

17 papers receiving 505 citations

Peers

Shalom Lerrer
Comparison fields: 5 of 74
  • Oncology 278
  • Immunology 226
  • Molecular Biology 202
  • Cancer Research 122
  • Pulmonary and Respiratory Medicine 51
Replace Ihor Arkhypov with:
Ihor Arkhypov Germany
Natalie McGregor United States
Samantha Lasser Germany
Antonia N. Policheni Australia
Dina Morein Israel
Junya Ohtake Japan
Mariano F. Zacarías Fluck Spain
Maria Corallo Italy
Audrey Champagne Canada
Shalom Lerrer relative to Ihor Arkhypov Germany Ihor Arkhypov's profile →
Citations per field
00.5×5.3×
Ihor Arkhypov · 1×
Citations per year

Countries citing papers authored by Shalom Lerrer

Since Specialization
Citations

This map shows the geographic impact of Shalom Lerrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shalom Lerrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shalom Lerrer more than expected).

Fields of papers citing papers by Shalom Lerrer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shalom Lerrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shalom Lerrer. The network helps show where Shalom Lerrer may publish in the future.

Co-authorship network of co-authors of Shalom Lerrer

This figure shows the co-authorship network connecting the top 25 collaborators of Shalom Lerrer. A scholar is included among the top collaborators of Shalom Lerrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shalom Lerrer. Shalom Lerrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 4
2 2
3 6
4 4
5 41
6 11
7 15
8 21
9 6
10 4
11 138
12 49
13 1
14 3
15 28
16 65
17 109

About Shalom Lerrer

Shalom Lerrer is a scholar working on Oncology, Immunology and Cancer Research, having authored 17 papers that have together received 507 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Immune Cell Function and Interaction (7 papers) and CAR-T cell therapy research (6 papers). The work is most often cited by research in Immunology (226 citations), Oncology (278 citations) and Cancer Research (122 citations). Shalom Lerrer has collaborated with scholars based in United States, Israel and Germany. Frequent co-authors include Adit Ben‐Baruch, Tsipi Meshel, Yulia Liubomirski, Stefan Wiemann, Cindy Körner, Dina Morein, Adam Mor, Kieran Adam, Rotem Feniger-Barish and Alexander Bott. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026